GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LTS:0QLR) » Definitions » Shiller PE Ratio

Novartis AG (LTS:0QLR) Shiller PE Ratio : 18.03 (As of May. 18, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Novartis AG Shiller PE Ratio?

As of today (2024-05-18), Novartis AG's current share price is CHF93.37. Novartis AG's E10 for the quarter that ended in Mar. 2024 was CHF5.18. Novartis AG's Shiller PE Ratio for today is 18.03.

The historical rank and industry rank for Novartis AG's Shiller PE Ratio or its related term are showing as below:

LTS:0QLR' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.78   Med: 16.94   Max: 21.68
Current: 17.9

During the past years, Novartis AG's highest Shiller PE Ratio was 21.68. The lowest was 12.78. And the median was 16.94.

LTS:0QLR's Shiller PE Ratio is ranked better than
68.91% of 534 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs LTS:0QLR: 17.90

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis AG's adjusted earnings per share data for the three months ended in Mar. 2024 was CHF1.164. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is CHF5.18 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novartis AG Shiller PE Ratio Historical Data

The historical data trend for Novartis AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Shiller PE Ratio Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.84 19.66 16.02 16.45 16.42

Novartis AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.22 17.37 18.16 16.42 16.75

Competitive Comparison of Novartis AG's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Novartis AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Shiller PE Ratio falls into.



Novartis AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis AG's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=93.37/5.18
=18.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Novartis AG's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.164/107.3549*107.3549
=1.164

Current CPI (Mar. 2024) = 107.3549.

Novartis AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.923 101.517 0.976
201409 1.227 101.247 1.301
201412 0.595 100.704 0.634
201503 5.213 100.339 5.578
201506 0.699 100.464 0.747
201509 0.749 99.785 0.806
201512 0.438 99.386 0.473
201603 0.824 99.475 0.889
201606 0.727 100.088 0.780
201609 0.788 99.604 0.849
201612 0.408 99.380 0.441
201703 0.701 100.040 0.752
201706 0.804 100.285 0.861
201709 0.847 100.254 0.907
201712 0.829 100.213 0.888
201803 0.815 100.836 0.868
201806 3.277 101.435 3.468
201809 0.668 101.246 0.708
201812 0.506 100.906 0.538
201903 0.760 101.571 0.803
201906 2.875 102.044 3.025
201909 0.882 101.396 0.934
201912 0.481 101.063 0.511
202003 0.911 101.048 0.968
202006 0.771 100.743 0.822
202009 0.769 100.585 0.821
202012 0.817 100.241 0.875
202103 0.846 100.800 0.901
202106 1.162 101.352 1.231
202109 1.126 101.533 1.191
202112 6.668 101.776 7.034
202203 0.920 103.205 0.957
202206 0.747 104.783 0.765
202209 0.701 104.835 0.718
202212 0.633 104.666 0.649
202303 1.000 106.245 1.010
202306 0.999 106.576 1.006
202309 0.765 106.570 0.771
202312 3.511 106.461 3.540
202403 1.164 107.355 1.164

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novartis AG  (LTS:0QLR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novartis AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novartis AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (LTS:0QLR) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG (LTS:0QLR) Headlines

No Headlines